<<
>>

THE LITERATURE LIST

1. Ajlamazjan, E.K.obstetrics. A national management / E.K.Ajlamazjan, V.I.Kulakov, V.E.Radzinsky, G.M.Saveleava. – GEOTAR – Media. - 2009.

– 1200 with.

2. Arzhanova, O.R.Ekspressija of biogenic amines at placental insufficiency / O.R.Arzhanova, I.M.Kvetnoj, A.V.Kuznetsova//Magazine akush zhensk illnesses.

– 2006. - №55. - release 1. – With. 44 – 49.

3. Bekman, CH Obstetrics and gynecology / C.Bekman, F.Ling, B.Barzhanski, etc.

- M: the Medical literature. – 2004. – 584 with.

4. Eljutin, D.V.endogenous an intoxication at women with gestozom, transferred a Cesarean section / D.V.Eljutin, D.V.Sadchikov, N.JU.Shanin, etc.//Akush Ginek. – 2002. - №1. – With. 20 – 23.

5. Kobchikova, A.V.research of level gomotsisteina and indicators of a hereditary thrombophilia at pregnant women with gestozom / A.V.Kobchikova, A.V.Arutyunyan, M.S.Zajnullina, etc.//Magazine akush zhensk illnesses. – 2012. - 61 (2). – with. 21 – 26.

6. Koshelev, N.G.system of a hemostasis and immunomorfologichesike placenta conditions at antifrsfolipidnyh antibodies in plasma / N.G.Koshelev, O.N.Zubzhitskaja, O.N.Arzhanova, etc.//Magazine akush and zhensk illnesses. – 2004. - №53. – with. 22-26.

7. Kulikov, A.V.clinico of feature of a HELLP-syndrome /

A.V.Kulikov, S.V.Spirin, S.I.Blauman//Anesthesia reanimatol. – 2010. -

№6. – WITH. 87-91.

8. Makarov, I.O.current of pregnancy and sorts at patients with adiposity / I.O.Makarov, E.I.Borovkova, M.J.Bajramova//Akush Ginek Reprod. – 2011. - №1. – With. 22 – 28.

9. Makarov, O.V.Arterialnaja a hypertensia at pregnant women. Whether only gestoz? / O.V.Makarov, N.N. Nikolaev, E.V.Volkova. - M.:ГЭОТАР-Медиа, 2006. – 174с.

10. Makarov, O.V.Znachenie of autoantibodies in a pathogenesis preeklampsii/

O.V.Makarov, JU.A.Bogatyryov, N.A.Osipov//Akush ginek. – 2012. - 4 (1).

– WITH. 16 – 21.

11. Makarov, O.V.Perspektivy of diagnostics and preeclampsia forecasting / O.V.Makarov, E.V.Makarov, E.V.Volkova//Ross the bulletin akush-ginek. – 2012. - 12 (1). – With. 35 – 42.

12. Manuhin, I.B.optimisation of complex treatment of pregnant women with gestozom and fetoplacental insufficiency / I.B.Manuhin, E.V.Markova, R.I.Strjuk//the Russian bulletin of the accoucheur-gynecologist. – 2012. - №2. – with. 81 84.

13. Mihajlova, and their microparticles in peripheric blood at physiological pregnancy and at gestoze / V.A.Mihajlova, O.M.Ovchinnikova, S.A.Selkov, etc.//Magazine akush zhensk illnesses. – 2012. - 61 (1). – with. 47 54.

14. Norvitts, E.R.evident obstetrics and gynecology / E.R.Norvitts, D.O.Shardzh. – M: GEOTAR-HONEY, 2003. - 144 with.

15. Pauls, O.V.Immunologija of a reproduction: old dogmas and new representations / O.V.Pavlov, S.A.Selkov//Magazine akush zhensk bolezn. – 2004. № 1.-S.89-97.

16. Pogorelov, V.M.Trombotsitarnye parametres at normally proceeding pregnancy and gestoze / V.M.Pogorelov, G.I.Kozinets, I.O.Makarov, etc.//Akush ginek a reproduction. – 2012. - №3. – with. 28 – 33.

17. Priority national projects "Health".

– M: GEOTAR-MEDIA, 2006. – 59 with.

18. Radzinsky, V.E.Akusherskaja aggression / V.E.Radzinsky. – M: magazine Status Praesens Publishing house, 2011.688 with.

19. Radzinsky, V.E.Sovremennye of technology of a phytotherapy in obstetrics and gynecology / V.E.Radzinsky//Magazine akush zhensk illnesses. – 2003. - №1.

– WITH. 83-88.

20. Rumjantsev, P.O.Statisticheskie analysis methods in clinical practice /

P.O.Rumjantsev, V.A.Saenko, U.V.Rumjantseva, S.J.Chekin//Problems

Endocrinologies. – M: Media Sphere, 2009. – Volume 55. №5. – With. 48-55.

21. Serov, V.N.Profilaktika of complications of pregnancy of high risk /

V.N.Serov//Effective pharmacotherapy. – 2011. - №2. – with. 82-83.

22. Serov, V.N.Eklampsija / V.N.Serov, S.A.Markin, A.J.Lubnin. – M: MIA, 2002. – 464 with.

23. Sidorov, I.S.new data about a genesis gestoza and an estimation of degree of its gravity / I.S.Sidorov, A.G.Gabibov, N.A.Nikitin//Akush Ginek. – 2006. - №6. – With. 10-14.

24. Sidorov, I.S.endothelial dysfunction in development gestoza /

I.S.Sidorov, I.L.Galinova//Questions ginek akush perinat. – 2006. -

5 (1). – WITH. 75-81.

25. Stepanova, R.N.Beremennost and immunity aberrations / R.N.Stepanova. –

M: the Companion Plus, 2013. - 135с.

26. Stepanova, R.N.Zabolevanija of a neck of a uterus at pregnant women: maternal and perinatalnye outcomes / R.N.Stepanova, E.V.Kolomeets//Ross Honey the Bulletin. – 2010. - 15 (4). – with. 38 – 45.

27. Stepanova, R.N.Nevynashivanie of pregnancy in Tajikistan: the reasons, risk factors, the forecast, preventive maintenance: dis.... d-ra.med.nauk: 14.00.01 / Stepanova Rimma Nikolaevna. - M, 1994. - 226с.

28. Stepanova, R.N.Profilaktika suboptimum maternal and perinatalnyh outcomes of pregnancy of high risk OpG-gestoza / R.N.Stepanova//Ross Bестник akush ginekol. – 2001. - №1. – With. 43-45.

29. Stepanova, R.N.Preeklampsija: epidemiologija, the forecast, preventive maintenance /

R.N.Stepanova. – LAP, - 2013. – 248 with.

30. Sulejmanova, N.S.role of antigens gistosovmestimosti at physiological and pathological pregnancy / N.S.Sulejmanova, N.V.Zaretsky, S.A.Timoth, etc.//Akush Ginek. – 2001. - №5. – With. 3-4.

31. Tarasova, L.P.maternal a case rate and a mortality in the Oryol area: the reasons, risk factors, the forecast, preventive maintenance: an autoref. dis.... kand. Medical sciences: 14.00.01 / Tarasova Lyudmila Petrovna. – M, 2008. – 26 with.

32. Tokova, Z.Z.Gestoz and a maternal lethality / Z.Z.Tokova, O.G.Frolov//

Ross Bестник akush-ginek. – 2005. - 5 (3). – With. 52-55.

33. Tjutjunnik, V.L.Diagnostika and treatment of placental insufficiency at pregnant women with a varicose phlebectasia of a small basin / V.L.Tjutjunnik, D.M.Magomethanova//RMZH. – 2007. - 15 (17). – With. 1289-1293.

34. Hofmejr, D.JU.Kokranovsky a management: pregnancy and labours.

Preventive maintenance hypertensive rasstorojstv / D.J.Hofmejr, D.P.nejlson, Z.Alfirevich, etc.; on red. G.Suhih. – M: Logosfera, 2010. – With. 55-69.

35. SHemanaeva, T.V.clinicodiagnostic and prognostic value of markers endtelioza at gestoze: an autoref dis.... kand. Medical sciences: 14.01.01 / Shemanaeva Tatyana Viktorovna. - M, 2008. – 24 with.

36. SHemanaeva, T.V.prognostic the importance of molecules of adhesion of cells of vessels in a severity level estimation gestoza / T.B.Shemanaeva, I.S.Sidorov, O.I.Gurin//Akush Ginek. – 2008. - №2. – With. 16-22.

37. Aardema, M.W. Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age foetuses / M.W. Aardema, H. Oosterhof, A. Timmer et al.//Placenta. – 2001. – N.22. – P. 405-411.

38. Abumaree, M.N. Trophoblast debris modulates the expression of immune proteins in macrophages: a rty to maternal tolerance of the foetal allograft / M.N. Abumaree,

L.W. Chamley, M. Badri et al.//J Reprod Immunol. – 2012. – Vol.94, N.2. – P. 131 – 141.

39. Agarwal, A. Role of oxidative stress in female reproduction / A. Agarwal,

S. Gupta, R. Sharma//Reprod Biol Endocrinol. – 2005. – N.3. – P. 28.

40. Akolekar, R. Maternal plasma inhibin A at 11 – 13 weeks of gestation in hypertensive disorders of pregnancy / R. Akolekar, R. Minekawa, A. Veduta et al.

//Prenat Diagn. – 2009. – N.29. – P. 753 – 760.

41. Akolekar, R. Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 13 weeks of gestation in preeclampsia /

R. Akolekar, J.Cruz, J-M. Foidart et al.//Prenatal Diagnosis. – 2010. – N.30. - P.

191-197.

42. Akolekar, R. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11 – 13 weeks /

R. Akolekar, Syagelaki, R. Sarquis et al.//Prenat Diagn. – 2011. – N.31. – P. 66 – 74.

43. Aksornphusitaphong, A. Risk factors of early and late onset pre-eclampsia /

A. V. Phupong//J. Obstet. Gynaecol. Res. – 2013. - Vol. 39,

- N.3. – P. 627–631.

44. Al-Balushi, M.S. Fluctuation in the levels of immunoglobulin M and immunoglobulin G antibodies for cardiolipin and β2-Glycoprotein among healthy pregnant women / M.S. Al-Balushi, S.S. Hasson, E.A. Said et al.//Sultan Qaboos Univ Med J. – 2014. – Vol.14 (4). – P. e478–e485.

45. Anastasakis, E. Association between abnormal uterine artery Doppler flow velocimetry, risk of preeclampsia, and indices of arterial structure and function /

E. Anastasakis, K. Paraskevas, N. Papanfoniou et al.//Angiology. – 2008. – Vol.59, N4. – P. 493-499.

46. Anna, R.D. Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction / R.D. Anna, G. Baviera,

F. Corrado et al.//Acta Obstet Gynecol Scand. – 2004. – Vol.83, N.2. – P. 155 158.

47. Askie, L.M. Antiplatelet agents for prevention of preeclampsia / L.M. Askie,

L. Duley, D. Henderson-Smart et al.//Lancet.–2007.–Vol.369, N.9575. - P.1791 - 1798.

48. Bahado-Singh, R.O. First-trimester metabolomic detection of late-onset preeclampsia / R.O. Bahado-Singh, R. Akolekar, R. Mandal et al.//AJOG. – 2013.

– Vol.208, - N.1. – P. 58.

49. Barton, J.R. Prediction and prevention of recurrent preeclampsia//J.R. Barton,

B.M. Sibai//Obstet Gynecol. – 2008. – N.112. – P. 359–372.

50. Baschat, A.A. Prediction of preeclampsia utilising the first trimester screening examination//A.A. Baschat, L.S. Magder, L.E. Doyle et al.//American Journal of

Obstetrics AND Gynecology. – 2014. – Vol.211, - N.5. – P. 514.

51. Baumann, M.U. Serum markers for predicting pre-eclampsia / M.U. Baumann,

N.A Bersinger, D.V. Surbek//Mol aspects Med. – 2007. – Vol.28, N.2. – P. 227 244.

52. Berlac, J.F. Obstetrical and neonatal outcomes in women following gastric bypass: a Danish national cohort study / J.F. Berlac, C.W. Skovlund, O. Lidegaad et al.//AOGS. – 2014. - Vol. 93, - N.5. – P. 454-462.

53. Bersinger, N.A. SECOND - and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies / N.A. Bersinger,

R.A. Odegard//Acta Obstet Gynecol Scand. – 2004. – Vol.83, N.1. – P. 37-45.

54. Bezerra Maia e Holanda Moura, S. Prevention of preeclampsia / S. Bezerra Maia e Holanda Moura, L Marques Lopes, P. Murthi et al.//Journal of Pregnancy. - 2012. - Vol.2012. - Article ID 435090, 9 pages.

55. Bigelow, C.A. Risk factors for new-onset late postpartum preeclampsia in women without a history of preeclampsia / C.A.Bigelow, G.A. Pereira, A. Warmsley et al.

//Am J Obstet Gynecol. – 2014. – Vol.210, N.4. – P. 338.

56. Black, M. Outcomes of pregnancy in women using illegal drugs and in women who smoke cigarettes//M. Black, S. Bnattacharya, T. Faivley, D.M. Campbell, A.S. Shetty//AOGS. – 2013. - Vol. 92, - N.1. – P. 47-52.

57. Bramham, K. Adverse maternal and perinatal outcomes in women with previous preeclampsia / K. Bramham, A. Briley, P. Seed et al.//Am J Obstet Gynecol. – 2011. – Vol.204, N.6. – P. 512e1-e9.

58. Branch, D.W. Antiphospholipid syndrome: obstetric diagnosis, management and controversies / D.W. Branch, M.A. Khamashta//Obstet Gynecol. – 2003. – N.101.

– P. 1333-1344.

59. Briceffio-Perez, C. Prediction and prevention ofr preeclampsia / C. BRICEFFIO - Perez, L. Briceffio-Sanabria, P. Vigil-DeGracia//Hypertens Pregnancy. – 2009. – Vol.28, N.2. – P. 138 – 155.

60. Buchimschi, C.S. Fractional excretion of angiogenic factors in women with several preeclampsia / C.S. Buchimschi, L. Magloire, E. Funai//Obstet Gynecol. – 2006.

– N.107. – P. 1103-1113.

61. Buchimschi, C.S. Urinary angiogenic factors cluster hypertensive disorders and identific women with severe preeclampsia / C.S. Buchimschi, E.R. Norwitz,

E. Funai et al.//Am J Obstet GYNECOL. - 2005. – Vol.192, N.3. – P. 734-741.

62. Bujold, E. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis / E. Bujold, F.V.Morency, S.Roberge et al.//J Obstet Gynecol Can. – 2009. – Vol.31, N.9. – P. 818-826.

63. Bujold, E. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy / E. Bujold, S. Roberge, Y. Lacasse et al.//Obstet Gynecol. – 2010. – Vol.116, N.2, part1. – P. 402-414.

64. Cakovic, M. Fractional excretion of tumour necrosis FACTOR - α women with severe preeclampsia / M. Cakovic, C. Buhimschi, G. Zhao et al.//Obstet Gynecol. 2008. - N.112,1. – P. 93-100.

65. Canini, S. Assosiation between birth weigth and first-trimester free β-human chorionic gonadotropin and pregnancy-associated plasma protein A / S. Canini,

F. Prefumo, D. Pastorino et al.//Fertil Steril. – 2008. – Vol.89, N.1. – P. 174 – 178.

66. Canniggia I. Oxygen and placental development during the first trimester: implications for the pathophysiology of preeclampsia I. Canniggia, J. Witer,

S.J. Lye, M. Post//Placenta. – 2000. – N.21, supplA. - S25-S30.

67. Carty, D.M. Novel biomarkers for predicting preeclampsia / D.M. Carty, Ch. Delles, A.F. Dominiczak//Trends Cardiovasc Med. – 2008. – N.18. – P. 186 – 194.

68. Castellino, G. Uterine artery doppler in predicting pregnancy outcome in women with connective tissue disorders / G. Castellino, R. Capucci, M. Govoni et al.//Rheumatology. – 2006. – Vol.45, N.9. – P. 1174-1175.

69. Chaiworapongsa, T. Pre-eclampsia part 1: current understanding of its pathophysiology / T. Chaiworapongsa, P. Chaemsaithong, L. Yeo et al.//Nature Reviews Nephrology. – 2014. – Vol.10. – P. 466–480.

70. Chaiworapongsa, T. Pre-eclampsia part 2: prediction, prevention and management

/ T. Chaiworapongsa, P. Chaemsaithong, S.J. Korzeniewski et al.//Nature Reviews Nephrology. – 2014. – Vol.10. – P. 531–540.

71. Chaiworopongsa, T. Evidence supporting a role for blocade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia /

T. Chaiworopongsa, R. Romero, J. Espinoza et al.//Am J Obstet Gynecol. – 2004.

– Vol.190, N.6. – P. 1541-1550.

72. Clark, E.A.S. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? E.A.S. Clark, R.M. Silver, D.W. Branch et al.//Current Rheumatology Reports. - 2007, - Vol.9, - N.3. – P. 219-225.

73. Cnattingius, S. The paradoxical effect of smoking in preeclamptic pregnancies /

S. Cnattingius, J. Mills, J. Yuen//Am J Obstet Gynecol. – 1997. – Vol.177, N.1. – P. 156-161.

74. Cnossen, J.S. Use of uterine artery Doppler ultrasonography to predict PRE - eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis / J.S. Cnossen, R.K. Morris, G. Riet et al.//CMAJ. – 2008. – N.178.

– P. 701-711.

75. Coghill, S. Risk factors for eclampsia: a population-based study in Washington State, 1987 – 2007 / S. Coghill, S. Hansen, A.J. Littman//Fm J Obstet Gynecol. – 2011. – Vol.205, N.6. – P. 553e1 – 553e7.

76. Conde-Agudelo, A. Maternal morbidity and mortality associated with interpregnancy interval / A. Conde-Agudelo, J.M. Belizan//Br Med J - 2000. N.321 – P.1255-1259.

77. Conde-Agudelo, A. Supplementation with vitamin C and vitamin E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcome / A. Conde-Agudelo, R. Romero, J. Kusanovic, S. Hassan//Am J Obstet Gynecol.-2011. – Vol.204, N.6. – P. 503e1-e12.

78. Conde-Agudelo, A. World health organisation systematic review of screening tests for preeclampsia / A. Conde-Agudelo, J. Villar, M. Lindheimer//Obstet Gynecol.

– 2004. – Vol.104, N.6. – P. 1367-1391.

79. Coonrod, D.V. Ethnicity, acculturation and obstetric outcomes / D.V. Coonrod,

R.C. Bay, H. Balcazar//J Reprod Med. – 2004. – Vol.49, N.1. – P. 17-22.

80. Costa, S. Early screening for preeclampsia / S. Costa, P. Murthi, R. Keogh, N.Woodrow//Rev Bras Ginecol Obstet. – 2011. Vol.33, N.11. – P. 367 – 375.

81. Crispi, F. Predictive value of angiogenic factors and uterine artery Doppler for EARLY - versus late-onset pre-eclampsia and intrauterine growth restriction /

F. Crispi, E. Llurba, C. Dominguez et al.//Ultrasound Obstet Gynecol. - 2008. – Vol. 31, - N.3. – P. 303–309.

82. Cuckle, H. Current controversies in prenatal diagnosis 4: pregnancy complications due to placental vascular disease (pre-eclampsia, FGR): are we ready for prevention / H. Cuckle, P. von Dadelszen, A. Ghidini//Prenatal Diagnosis. – 2013. – Vol.33, - N.1. – P. 17–20.

83. Cunningham, F.G. Williams Obstetrics, 22th ed NY-Toronto / F.G. Cunningham,

K.J. Leveno, S.L. Bloom et al. MC GRAW-Hill, 2005.

84. D'Antonio, F. Comparison of wavelet transform and time-domain analysis of second trimester uterine artery doppler waveforms in screening for pre-eclampsia /

F. D'Antonio, P. Hamilton, R.Pinnock et al.//Fetal Diagn Ther. – 2013. - Vol. 33, - N.3. – P. 189-193.

85. Dekker, G. Primary, secondary and tertuary prevention of pre-eclampsia / G. Dekker, B.Sibai//Lancet. – 2001. – N.357. – P. 209 – 215.

86. Dekker, G.A. Etiology and pathogenesis of preeclampsia: current concepts /

G.A. Dekker, B.M. Sibai//Am J Obstet Gynecol. – 1998. – N.179. – P. 1359 1375.

87. Dreyfus, M. Antiphospholipid antibodies and preeclampsia: a case-control study /

M. Dreyfus, G.Hedelin, R. Kutnahorsky et al.//Obstetrics AND Gynecology. – 2001.

- Vol. 97, - N. 1.

88. Duckitt, K. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies / K. Duckitt, D.Harrington//Br Med J - 2005.-N.330. - P.565–569.

89. Duley, L.J. Antiplatelet drugs for prevention of pre-eclampsia and its

consequences: systematic review / L.J. Duley, D. Henderson-Smart, M. Knight//Brit Med J. – 2001. – N.322. – P. 329-333.

90. Esplin, M.S. Paternal and maternal components of the predisposition to preeclampsia / M.S. Esplin, M.B. Fausett, A. Fraser et al.//N Engl J Med. – 2001.

– N.344. – P. 867-872.

91. Gernand, A.D. Maternal vitamin D status and Small-for-gestational-age offspring in women at high risk for preeclampsia / A.D. Gernand, H.N. Simhan, S. Caritis//Obstetrics AND Gynecology. – 2014. – Vol.123, N.1. – P. 40-48.

92. Giguere, L. Combining biochemical and ultrasonographic markers in predicting preeclampsia / L. Giguere, M. Charland, E. Bujold et al.//Clinical Chemistry. – 2010. – Vol.56, N.3. – P. 361 – 374.

93. Goetzinger, K.R. Efficiency of first-trimester uterine artery doppler, a-disintegrin and metalloprotease 12, pregnancy-associated plasma protein A, and maternal characteristics in the prediction of preeclampsia / K.R. Goetzinger, Y. Zhong,

A.G. Cahill et al.//J Ultrasound Med. – 2013. - Vol.32, - N.9. – P. 1593-1600.

94. Goetzinger, K.R. Predicting the risk of pre-eclampsia between 11 and 13 weeks gestation by combining maternal characteristics and serum analites, PAPP-A and free b-hCG / K.R. Goetzinger, A. Singla, S.Gerkovitcz//Prenat Diagn. – 2010. – VOL.30, N.12-13. – P. 1138 – 1142.

95. Goldenberg, R.L. Maternal mortality / R.L. Goldenberg, E.M.McClure//Am J Obstet Gynecol. – 2011. – N.205. – P. 293 – 295.

96. Gonen, R. Placental protein13 as early marker for pre-eclampsia / R. Gonen, R. Shahar, Y. Grimpel et al.//BJOG. - 2008. – N.115. – P. 1465 – 1472.

97. Grill, S. Potential markers of preeclampsia-review / S.Grill, C. Rusterholz,

R. Zanetti-Dallenbach et al.//Reprod Biol Endocrinol. – 2009. – N.7. – P. 70-93.

98. Grobman, W.A. Serum levels of activin A and inhibin A and the subsequent development of pre-eclampsia / W.A. Grobman, J. Eileen//Obstet Gynecol. – 2000. – Vol.96, N.3. – P. 390–394.

99. Gurgel Alves, J.A. First-trimester maternal ophthalmic artery Doppler analysis for prediction of pre-eclampsia / J.A. Gurgel Alves, P.C. Praciano de Sousa,

S. Bezerra Maia e Holanda Moura et al.//Ultrasound Obstet Gynecol. - 2014. – Vol.44, - N.4. – P. 411–418.

100. Hairong, Xu. Role of nutrition in the risk of preeclampsia / Xu. Hairong,

B. Shatenstein, Luo Zhong-Cheng et al.//Nutrition rev. – 2009. – Vol.67, N.11. – P. 639-657.

101. Hai-Tao, Yuan. Angiogenic factors in the pathogenesis of preeclampsia / Yuan.

Hai-Tao, D. Haig, A.Karumanchi//Cur Top Development BIOL.-2005.-N.71. - P.297-312.

102. Hanisch, C.G. Adhesion molecules, activin and inhibin candidates for the biochemical prediction of hypertensive diseases in pregnancy? / C.G. Hanisch,

K.A. Pfeiffer, H. Schlebusch, J. Schmolling//Arch. Gynecol Obstet. – 2004. – Vol.270, N.2. – P. 110-115.

103. Hayashi, M. Elevation of serum macrophage colony-stimulating factor before the clinical manifestations of preeclampsia / M. Hayashi, T. Ohkura, N. Inaba//Am J Obstet Gynecol. – 2003. – N.189. – P. 1356-1360.

104. Heyborne, K.D. Preeclampsia prevention: lessons from the low-dose aspirin therapy trials / K.D. Heyborne//Am J Obstet Gynecol. – 2000. – Vol.183, N.3. – P. 523-528.

105. Hofmeyr, G.J. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems / G.J. Hofmeyr, T.A. Lawrie,

A.N. Atallach, L.Duley. - Cochrane Database Syst Rev. - 2010 (8), CD001059.

106. Hofmeyr, G.J. Dietary calcium supplementation for prevention of pre-eclampsia and related problems / G.J. Hofmeyr, L. Duley, A.Atallah//BJOG. – 2007. – N.114. – P. 933 – 943.

107. Hogberg V. The effect of smoking and hypertensive disorders on abruptio placentae / V.Hogberg, S. Rasmussen, L.M. Irgens//Acta Obstet Gynecol Scand.

– 2007. – Vol.86, N.3. – P. 304-309.

108. Hogg, B. Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia and intrauterine growth restriction / B.Hogg, T Tamura, K. Johnston et al.//Am J Obstet GYNECOL. - 2000. N.183. - P.805-809.

109. Hypponen, E. Vitamin D for the prevention of preeclampsia? A hypothesis /

E. Hypponen//Nutrition Reviews J. – 2005. – Vol.63, N.7. – P. 225-232.

110. Imdad, A. Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders / A. Imdad, A. Jabeen, Z.A.Bhutta//BMC Public Health. – 2011. – N.11, suppl 3. - S18.

111. Inversetti, A. Predictive biomarkers of pre-eclampsia and effectiveness of preventative interventions for the disease / A. Inversetti, M. Smid, M. Candiani et al.//Expert Opinion on Biological Therapy. - 2014. - Vol.14, - N.8. – P. 1161 1173.

112. Kane, S.C. New directions in the prediction of pre-eclampsia / S.C. Kane,

F. Da Silva Costa, S.P. Brennecke//ANZJOG Australian and New Zealand Journal of Obstetrics and Gynaecology. – 2014. – Vol.54, - N.2. – P. 101–107.

113. Kane, S.C. Contemporary clinical management of the cerebral complications of preeclampsia / S.C. Kane, A. Dennis, F. da Silva Costa et al.//Obstetrics and Gynecology International. – 2013. – Vol.2013. - Article ID 985606, 10 pages.

114. Khalil, A. First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk / A. Khalil, N.J. Cowans, K. Spenser et al.//Ultrasound Obstet Gynecol. – 2010. – Vol.35, - N.6. – P. 671–679.

115. Kilari, A. A novel molecular mechanistic hypothesis to validate the therapeutic effects of tribulus terrestris (Gokshur) to ameliorate pathophysiology and improve pregnancy and foetal outcome in preeclampsia / A. Kilari, M. Deshpande, S. Joshi//Gynecol Obstet (Sunnyvale). – 2014. – Vol.4 – N.1. – P. 1-7.

116. Kim, Shin-Young. Maternal plasma and amniotic fluid SFLT-1 and PLGF levels at the time of MID - trimester amniocentesis in women who subsequently develop preeclampsia / Shin-Young Kim, Hyun-Mee Ryu, Jag-Hyng Jang//Am J Obstet Gynecol – 2006. – Vol.195, N.6, suppl 130.

117. Kliman, H.J. Placental protein13 and decidual zones of necrosis: immunologic diversion that may by linked to pre-tclampsia / H.J. Kliman, M. Sammar,

Grimpel et al.//Reproductive Science. – 2011.–N.0. – P. 1 – 15.

118. Koga, K. Elevated serum soluble vascular endothelial growth factor receptor 1

(sVEGFR-1) levels in women with preeclampsia / K. Koga, Y. Osuga, O. Yoshino et al.//J Clin Endocrinol Metab. – 2003. – Vol.88, N.5. – P. 2348-2351.

119. Kopcow, H. Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia / H. Kopcow, S.Karumanchi//J Reprod IMMUNOL.-2007.-N.7-P.23 - 29.

120. Kronborg, C.S. Longitudinal measurement of cytokines in preclamptic and normotensive pregnancies / C.S.Kronborg, J.G. Jedsted, E. Wittinghus et al.//Acta Obstet Gynecol Scand. – 2011. – Vol.90, N.7. – P. 791 – 796.

121. Lai, J. Maternal serum placental growth factor, pregnancy-associated plasma protein-A and free β-Human chorionic conadotrophin at 30-33 weeks in the prediction of pre-eclampsia / J. Lai, A. Pinas, L.C.Y. Poon et al.//Fetal Diagn Ther.-2013. - Vol.33, - N.3. – P. 164-172.

122. Lapaire, O. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application / O. Lapaire, A. Shennan, H.Stepan//Europ J Obstet Gynecol. – 2010.

– N.151. – P. 122-129.

123. Leslie, K. Early prediction and prevention of pre-eclampsia//K. Leslie,

B. Thilaganathan, A. Papageorghiou//Best Pract Res Clin Obstet Gynaecol. – 2011. – Vol. 25, N.3. – P. 343 – 354.

124. Leung, K.Y. First-trimester ultrasound volumetry / K.Y. Leung, T. Ma, B. Lau,

G. Minchen//Expert Rev Obstet Gynecol. – 2012. – Vol.7, N.4. – P. 379 – 386.

125. Levine, R.J. Circulating angiogenic factors and the risk of preeclampsia /

Levine, S.E. Maynard, C. Qian et al.//N Engl J Med. – 2004. – N.350. – P. 672-683.

126. Lim, J.H. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors / J.H. Lim, S.Y. Kim, S.Y. Park et al.//Obstet Gynecol. - 2008. – Vol.111, N.6. – P. 1403-1409.

127. Lindheimer, M.D. The roll-over test / M.D. Lindheimer, J.M. Roberts,

F.G. Cunningham//Sao Paulo Med. J. – 1997. – Vol. 115, N.5. – P. 1533-1536.

128. Liu, X.L. ANTI - β 2 glycoprotein I antibodies and pregnancy outcome in

antiphospholipid syndrome / X.L. Liu, J. Xiao, F. Zhu.//Acta Obstet Gynecol Scand. – 2013. – Vol.92, N.2. – P. 234-237.

129. Lopez-Mendez, M.A. Doppler ultrasound evaluation in preeclampsia /

M.A. Lopez-Mendez V. Martinez-Gaytan, R. Cortes-Flores et al.//BMC Research Note. – 2013, 6:477.

130. Machado, S. Diagnosis, pathophysiology and management of pre-eclampsia: a review / S. Machado, M. Neves, L. Freitas, M. Campos//Port J Nephrol Hypert. – 2013. – Vol. 27 (3). – P. 153-161.

131. MacKay, A. Pregnancy-related mortality from preeclampsia and eclampsia /

A. MacKay, C. Berg, H.Atrash//Obstet Gynecol. – 2001. – Vol.97, N.4. – P. 533 538.

132. Maynard, S. Preeclampsia and angiogenic imbalance / S.Maynard, F.H.Epstein, S.A.Karumanchi//Annu Rev Med. – 2008. – N.59 – P. 61-78.

133. Mazar, R.M. Metabolic score as a novel approach to assessng preeclampsia risk /

R.M. Mazar, S.K.Srinivas, M.D. Sammel et al.//Am J Obstet Gynecol. – 2007. - Vol.197, N4. – P. 411e1-e5.

134. Meiri, H. First trimester PP13 as a marker for prediction of pre-eclampsia /

H. Meiri, N. Chefetz, M. Sammar et al.//Biomarkers, CLI. - 2006

135. Melchiorre, K. First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia / K. Melchiorre, B. Wormald, K. Leslie et al.//Ultrasound Obstet Gynecol. – 2008. – Vol.32, - N.2. – P. 133–137.

136. Mello, G. Thrombophilia is significantly associated with severe preeclampsia results of a large-scale, case-controlled study / G. Mello, E. Parretti, L. Marozio et al.//Hypertension. – 2005. – Vol. 46. – P. 1270-1274.

137. Metcalfe, A. Prediction of obstetrical risk using maternal serum markers and clinical risk factors / A. Metcalfe, S. Langlois, J. MacFarlane et al.//Prenatal Diagnosis. – 2014. – Vol.34, - N.2. – P. 172–179.

138. Metz, T.D. Preeclampsia in high risk women is characterised by risk GROUP - specific abnormalities in serum biomarkers / T.D. Metz, A.A. Allshouse,

A.G. Euser, K.D. Heyborne//American Journal of Obstetrics AND Gynecology. –

2014. - Vol. 211, - N.5. – P. 512.

139. Minakami, H. Gestational thrombocytopenia / H. Minakami I. Sato//Lancet. – 2000. – N.356. – P. 1354-1355.

140. Molvarec, A. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parametres in women with pre-eclampsia / A. Molvarec, A. Szarka,

S. Walentin et al.//Hypertension Research. – 2010. – Vol.33. – P. 892-898.

141. Moore Simas, T.A. Angiogenic factors for the prediction of preeclampsia in HIGH - risk women / T.A. Moore Simas, S.L. Crawford, M.J. Solitro et al.//Am J Obstet Gynecol. – 2007. – N.197. – P. 244-248.

142. Morlin, B. Nitric oxide induces endometrial secretion at implantation time /

B. Morlin, E. Andersson, B.Bystrom//Acta Obstet Gynecol Scand. – 2005. – N.84. – P. 1029-1034.

143. Murphy, S.R. Role of endothelin in mediating soluble fms-like tyrosine kinase 1 induced hypertension in pregnant rats / S.R. Murphy, B. LaMarca, K. Cockrell,

J. Granger//Hypertension. – 2010. – N.55 – P. 394-398.

144. Myers, J.E. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study /

J.E. Myers, L.C. Kenny, L.M.E. McCowan et al.//BJOG. – 2013. – Vol.120, - N.10. – P. 1215–1223.

145. Napolitano, R. Uterine artery Doppler screening for pre-eclampsia: comparison of the lower, mean and higher first-trimester pulsatility indices / R. Napolitano,

R. Rajakulasingam, A. Memmo et al.//Ultrasound Obstet Gynecol. - 2011. – Vol. 37, - N.5. – P. 534–537.

146. National Institute for Health and Clinical Excellence. NICE clinical guideline 107.

Hypertension in pregnancy. The management of hypertensive disorders during pregnancy / NICE, - 2010.

147. Nicolaides, K.H. A novel approach to first-trimester screening for early PRE - eclampsia combining serum PP-13 and Doppler ultrasound / K.H. Nicolaides,

R. Bindra, O.M. Turan et al.//Ultrasound in Obstet Gynecol. – 2006. – Vol.27,

N.1. – P. 13-17.

148. North, R. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort / R. North, L. McCowan, G. Dekker et al.//BMJ. – 2011. - Vol.342. - d1875.

149. Odibo, A.O. FIRST - trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia / A.O. Odibo,

Y. Zhong, K.R. Goetzinger et al.//Placenta. – 2011. – N.32. – P. 598 – 602.

150. Odibo, A.O. Pregnancy associated-plasma protein-A (PAPP-A) and ALFA - fetoprotein (AFP) associated with placental abruption / A.O. Odibo//Am J Obstet Gynecol. – 2014. – Vol.211, N.2. – P. 89-90.

151. Onwudiwe, N. Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler and mean arterial pressure / N.Onwudiwe, C.K. Yu,

L.C. Poon et al.//Ultrasound Obstet Gynecol. – 2008. – Vol.32, N.7. – P. 877-883.

152. Ophir, E. Newborns of pre-eclamptic women: a biochemical difference present in utero / E. Ophir, G. Dourleshter, Y. Hirsh et al.//Acta Obstet Gynecol Scand. – 2006. – Vol.85, N.10. – P. 1172-1178.

153. Papageorghiou, A.T. Predicting and preventing pre-eclampsia—where to next? /

A.T. Papageorghiou//Ultrasound Obstet Gynecol. - 2008. – Vol.31, - N.4. – P. 367–370.

154. Parra, M. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markersof oxidative stress and endothelial dysfunction

/ M. Parra, R. Rodrigo, P. Barja//Am J Obstet Gynecol. – 2005. – VOL.193, N.4.

– P. 1486-1491.

155. Parra-Cordero, M. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy / M. Parra-Cordero, R. Rodrigo, P. Barja et al.//Ultrasound Obstet Gynecol. - 2013. – Vol.41, - N.5. – P. 538–544.

156. Pattison, N.S. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? / N.S. Pattison, L.W. Chamley,

M. Birdsall et al.//Am J Obstet Gynecol. – 2000. – N.183. – P. 1008-1012.

157. Payne, B. Performance of the fullPIERS model in predicting adverse maternal outcomes in pre-eclampsia using patient data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) cohort, collected on admission / B. Payne, S. Hodgson, J.A. Hutcheon et al.//BJOG. – 2013. – Vol.120, - N.1. – P. 113–118.

158. Petri, M. Pregnancy in SLE / M. Petri//Baillieres Clin Rheumatol. – 1998. - N12. – P. 151 155.

159. Pilalis, A. Scrining for preeclampsia and foetal growth restriction by uterine artery Doppler and PAPP-A at 11 – 14 weeks gestation / A. Pilalis, A.P. Souka,

P. Antsaklis et al.//Ultrasound Obstet Gynecol. – 2007. – N.29. – P. 135 – 140.

160. Pipkin, F.B. Risk factors for preeclampsia / F.B. Pipkin//N Engl J Med. - 2001. – N.344. – P. 925-926.

161. Plasencia, W. Uterine artery Doppler at 11 to 13 weeks in the prediction of PRE - eclampsia / W.Plasencia, N. Maiz, L. Poon, H. Nicolaides//Ultrasound. Obstet. Gynecol. - 2008. - Vol.32. - P.138 – 146.

162. Poon, L.C. First-Trimesters maternal serum pregnancy-associated plasma PROTEIN - A and pre-eclampsia / L.C. Poon, N. Maiz, C. Valencia et al.//Ultrasaund Obstet Gynecol. – 2009. - Vol 33. - P. 23-33.

163. Poon, L.C. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks / L.C. Poon,

V. Stratieva, S. Piras et al.//Prenat Diagn. – 2010. - Vol.30. - P. 216 - 223.

164. Prajapati, S.R. Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler, and mean arterial pressure (A Prospective Study of 200 Cases) / S.R. Prajapati, N. Maitra//The Journal of Obstetrics and Gynecology of India. – 2013. – Vol. 63 (1). – P. 32-36.

165. Rana, S. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia / S. Rana, S.A. Karumanchi, R.J. Levine//Hypertension. – 2007. – N.50. – P. 137-142.

166. Redman, C.W. Preeclampsia: an excessive maternal inflammatory response to pregnancy / C.W. Redman, G.P. Sacks, I.L.Sargent//Am J Obstet Gynecol. – 1999. – N.180. – P. 499-506.

167. Roberge, S. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis / S. Roberge, K. H. Nicolaides, S. Demers et al.

//Ultrasound in Obstetrics AND Gynecology. - 2013. – Vol.41, – N.5. – P. 491–499.

168. Roberts, J.M. The two stage model of preeclampsia: variations on the theme /

J.M. Roberts, C.A. Hubelab//Placenta. – 2009. – N.30, - P. 32-37.

169. Roberts, J.M. Vitamins C and E to prevent complications of pregnancy-associated hypertension / J.M. Roberts, L. Myatt, C.Y. Spong et al.//N Engl J Med. - 2010.

– Vol.362, N.14. – P. 1282-1291.

170. Roberts, M. Pathogenesis and genetics of pre-eclampsia / M. Roberts, D.Cooper//Lancet. – 2001. – N.357. – P. 53-56.

171. Rocha-Hernandez, J.F. Other predictive markers of pre-eclampsia / J.F. ROCHA - Hernandez, C. Zerquera-Gonzalez, M.A. Santos-Pena et al.//BMJ – 2008. – N.336 – P. 1079-1080.

172. Roes, E.M. First trimester inhibin-A concentrations and later development of preeclampsia / E.M. Roes, M. Gaytant, C. Thomas et al.//Acta Obstet Gynecol Scand. – 2004. – Vol.83, N.1. – P. 117

173. Rogers, E. Folate deficiency and plasma homocysteine during increased oxidative stress / E. Rogers, B. Shan Shen Chen, E.Chan//New Engl J Med. – 2007. – N.357. – P. 421-424.

174. Rossi, A.C. Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis / A.C.Rossi

//Eur J Obstet Gynecol Reprod Biol. – 2011. – Vol.158, N.1. – P. 9-16.

175. Ruano, R. Prevention of preeclampsia with low dose aspirin – a systematic review and meta-analysis of the main randomized controlled trials / R. Ruano, R. Fontes, M.//Zugaib Clinics. – 2005. – Vol.60, N.5. – P. 407-414.

176. Ruma, M. Maternal periodontal disease, systemic inflammation, and risk for preeclampsia / M. Ruma, K. Boggess, K. Moss et al.//Am J Obstet Gynecol. – 2008. – N.198. – P. 389-385.

177. Sanna, G. Central nervous system involvement in the antiphospholipid (Hughes) syndrome / G. Sanna, M.L. Bertolaccini, M.J. Guadrado et al.//Rheumatology. –

2003. – Vol.42, N.2. – P. 200-213.

178. Sawidou, M.D. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop PRE - eclampsia / M.D. Sawidou, A.D. Hingorani, D. Tsikas et al.//Lancet. – 2003. – N.361. – P. 1511-1517.

179. Saxena, A.R. First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia / A.R. Saxena,

E.W. Seely, J.W. Rich-Edwards et al.//BMC Pregnancy and Childbirth. - 2013, 13:85.

180. Scazzoccio, E. Performanse of a first trimester screening of preeclampsif in a routine care low-risk setting / E. Scazzoccio, F. Figueras, F. Crispi et al.//Am J Obstet Gynecol. – 2013. – Vol.208, N.3. – P. 203e1 – 203e10.

181. Schisterman, E.F. Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial / E.F. Schisterman, R.M. Silver, L.L. Lesher et al.//The Lancet. – 2014. – Vol.384, N.9937. – P. 29-36.

182. Schoofs, K. The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction / K. Schoofs,

U. Grittner, Th. Engels et al.//Journal of Perinatal Medicine. - 2014. – Vol.42, - N.1. – P. 61–68.

183. Shaarawy, M. Plasma endothelin-1 and mean arterial pressure in the prediction of pre-eclampsia / M. Shaarawy, A. Abdel-Magid//Int J Gynaecol Obstet. – 2000. – Vol.68, N.2. – P. 105-111.

184. Sibai, B. Pre-eclampsia / B. Sibai, G. Dekker, M. Kupferminc//Lancet. - 2005. – N.365. – P. 785-799.

185. Sibai, B.M. Prevention of preeclampsia. A big disappointment / B.M. Sibai//Am J Obstet Gynecol. – 1998. – N.179. – P. 1275-1278.

186. Simchen, M.J. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome / M.J. Simchen, M. Dulitzki, G. Rofe et al.//Acta Obstet Gynecol Scand. – 2011. – Vol.90, N.12. – P. 1428 – 1433.

187. Simone, N.D. Pregnancies complicated with antiphospholipid syndrome: the

pathogenic mechanism of antiphospholipid antibodies / N.D. Simone, M.P. Luigi, D'A. Marco et al.//Annals of the New York Academy of Sciences. – 2007. - Vol.1108. – P. 505–514.

188. Skjaerven, R. Recurrence of pre-eclampsia across generations exploring foetal and maternal genetic components in a population based cohort / R. Skjaerven,

L.J. Vatten, A.J. Wilcox et al.//BMJ – 2005. – Vol.331, N.7521. – P. 877.

189. Spencer, K. First trimester maternal serum PP-13, PAPP-A and second trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia / K. Spencer,

N.J. Cowans I. Chefetz et al.//Ultrasound in Obstet Gynecol J. – 2007. – Vol.29, N.2. – P. 128-134.

190. Spencer, K. Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia / K. Spencer, N.J. Cowans I. Chefetz et al.//Prenatal Diagnosis. – 2007. – Vol.27, N.3. – P. 258-263.

191. Spinnato, J.A. Antioxidant therapy to prevent preeclampsia: a randomized controlled trial / J.A. Spinnato, S. Freire, E. Pinto et al.//Obstet Gynecol. – 2007.

– Vol.110, N.60. – P. 1311-1318.

192. Stevens, D.U. Cardiovascular and thrombogenic risk of decidual vasculopathy in preeclampsia / D.U. Stevens, S. Al-Nasiry, M.M. Fajta, J. Bulten//Am J Obstet Gynecol. – 2014. – Vol.210, N.6. – P. 545.

193. Syngelaki, A. Body mass indexat 11 – 13 weeks gestation and pregnancy complications / A. Syngelaki, F.E. Bredaki, E. Vaikousi et al.//Fetal Diagn Ther.

– 2011. – N.30. – P. 250 – 265.

194. Szarca, A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array / A. Szarka,

J. Rigo, L. Lazar et al.//BMC Immunol. – 2010, 11: 59.

195. Taylor, R.N. Longitudinal serum concentrations of placental growth factor evidence for abnormal placental angiogenesis in pathologic pregnancies /

R.N. Taylor, J. Grimwood, R.S. Taylor et al.//Am J Obstet Gynecol. – 2003. – N.188. – P. 177-182.

196. Teixeira, P.G. Placental growth factor (PlGF) is a surrogate marker in preeclamptic

hypertension / P.G. Teixeira, A. Cabral, S. Andrade et al.//Hypertension in pregnancy. – 2008. – Vol.27, N.1. – P. 65-73.

197. Thilaganathan, B. Early-pregnancy multiple serum markers and second-trimester uterine artery doppler in predicting preeclampsia / B. Thilaganathan, B. Wormald,

C. Zanardini et al.//Obstet Gynecol. – 2010. – N.115. – P. 1233-1238.

198. Tidwell, S.C. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia / S.C. Tidwell, H.N. Ho, W.H. Chiu et al.//Am J Obstet Gynecol. – 2001. – N.184. – P. 1267-1272.

199. Tjwa, M. VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis / M. Tjwa, A. Luttun, M. Autiero et al.//Cell Tissue Res. – 2003. – N.314. – P. 5-14.

200. Tobinaga, C.M. Angiogenetic factors and uterine Doppler velocimetry in EARLY - and late-oncet preeclampsia / C.M. Tobinaga, M.R. Torloni, B.Y. Gueuvoghlanian-Silva et al.//AOGS. – 2014. – Vol. 93, - N.5. – P. 469-476.

201. Tranquilli, A.L. Placental expression of nitric oxide synthase during HELLP syndrome / A.L. Tranquilli, S.R. Giannubilo, E. Tedeschi et al.//Acta Obstet Gynecol Scand. – 2005. – N.84. – P. 849-853.

202. Tranquilli, A.L. Preeclampsia: no longer solely a pragnansy disease /

A.L. Tranquilli, B. Landi, S.R. Giannubilo, B. Sibai//Pregnancy Hypertens. – 2012. - Vol.2, N4. – P. 350 – 357.

203. Trivedi, N.A. A meta-analysis of low-dose aspirin for prevention of preeclampsia /

N.A. Trivedi//J Postgrad Med Year. – 2011. – Vol.57, - N.2 – P. 91-95.

204. Tyler, C.P. Brain damage in preterm newborns and maternal medication: the Elgan Study / C.P. Tyler, N. Paneth, E.N. Allred et al.//Am J Obstet Gynecol. – 2012. – N.207. – P. 192e1 – 192e9.

205. Vatten, L.J. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia / L.J. Vatten, A. Eskild, T. Nilsen et al.//Am J Obstet Gynecol. – 2007. – Vol.196, N.3. – P. 239e1-239e6.

206. Venkat-Raman, N. Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome / N. Venkat-Raman, T. May Backos,

W. Tech et al.//Obstet Gynecol. – 2001. – Vol.98, N.2. – P. 235-242.

207. Verloren, S. The sFlt-1/PIGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients / S. Verloren,

I. Herraiz, O. Lapaire//Am J Obstet Gynecol. – 2012. – Vol.206, N.1. – P. 58E1 - 58e8.

208. Villa, P.M. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials / P.M. Villa, E. Kajantie, K. Rikkonen et al.//BJOG. – 2013. – Vol.120, - N.1. – P. 64–74.

209. Walker, J.J. Pre-eclampsia / J.J. Walker//Lancet. – 2000. – N.356. – P. 1260 1265.

210. Walsh, C.A. Mean arterial pressure and prediction of preeclampsia / C.A. Walsh, L.V.Baxi//BMJ – 2008. – Vol.336, N.7653. – P. 1079-1080.

211. Wang, A. Preeclampsia: the role of angiogenic factors in its pathogenesis /

A. Wang, S. Rana, S.A. Karumanchi//Physiology. – 2009. – Vol.24, N.3. – P. 147-158.

212. Wei, Shu-Qn. Maternal plasma 25-hydroxyvitamin D levels, angiogenic factors and preeclampsia / Shu-Qn Wei, F. Audibert Zong-Cheng Luo et al.//Am J Obstet Gynecol – 2013. – Vol.208, N.5. – P. 390e1 – 390e6.

213. Wen, Shi Wu. Folic acid supplementation in early second trimester and the risk of preeclampsia / Shi Wu Wen, Xi–Kuan Chen, M. Rodger et al.//Am J Obstet Gynecol. – 2008. – N.198. – P. 45e1-45e7.

214. Whitecar, P.W. Altered expression of TCR-CD3zeta induced by sera from women with preeclampsia / P.W. Whitecar, K.A. Boggess, M.J. McMahon et al.//Am J Obstet Gynecol. – 2001. – N.185. – P. 812 – 818.

215. Whitley, G.S. Trophoblast-mediated spiral artery remodelling: a role for apoptosis

/ G.S. Whitley, J.E. Cartwright//Anat. – 2009. – Vol.215, N.1. – P. 21-26.

216. WHO. Mother-Baby Pakage. Geneva, - 1994. – 85 p.

217. WHO. Reduction of maternal mortality. WHO, Geneva, - 2005. – 41 p.

218. WHO: Trends in maternal mortality: 1990 to 2013. Estimates by WHO, UNICEF,

UNFPA, The World Bank and the United Nations Population Division. WHO, - 2014. – 56 p.

219. Xu Xiong. Maternal smoking and preeclampsia / Xu Xiong, Fu-Lin Wang,

S.T. Davidge//J Reprod Med. – 2000. – N.45. – P. 727-732.

220. Yamada, H. ANTI - β 2 glycoprotein-I antibody increases the risk of PREGNANCY - induced hypertension: a case-controlled study / H. Yamada, T. Atsumi,

O. Amengual et al.//Journal of Reproductive Immunology. - 2010. – Vol.84, - N.1. - P. 95–99.

221. Yaron, Y. Decreased first trimester PAPP-A is a predictor of adverse outcome /

Y. Yaron, S. Heifetz, Y. Ochshorn et al.//Prenat Diagnos. – 2002. – Vol.22 – P.778–82.

222. Yu, J. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia / J. Yu, C.Z. Shixia, Y. Wu,

T. Duan et al.//Ultrasound Obstet Gynecol. – 2011. – Vol.37. – P. 528–533.

223. Yulug, E. Apoptotic and morphological features of the umbilical artery endothelium in mild and severe pre-eclampsia / E. Yulug, E. Yenilmez, M. Unsal et al.//Acta Obstet Gynecol Scand. – 2006. – Vol.85, N.9. – P. 1038-1045.

<< | >>
A source: Kosova ANNA SERGEEVNA. PREEKLAMPSIA: MODERN APPROACHES TO FORECASTING AND PREVENTION. Thesis for the degree of candidate of medical sciences. Orel - 2015. 2015

More on topic THE LITERATURE LIST:

  1. the literature List the Scientific and educational literature
  2. the LIST of the USED LITERATURE the Literature in Russian
  3. THE LIST OF THE USED SOURCES AND THE LITERATURE
  4. THE LITERATURE LIST
  5. the list of the used literature
  6. the LITERATURE LIST
  7. the List of the used literature
  8. the literature list
  9. the List of the used literature
  10. THE LITERATURE LIST
  11. the List of the used literature
  12. THE LITERATURE LIST
  13. THE LITERATURE LIST
  14. the literature List